Xbrane Biopharma AB
Dorota Anna Klaczkowska is a Senior Scientist at Xbrane Biopharma AB, focusing on binding and potency assay development, collaborations with CROs, and projects involving biosimilars and immuno-oncology since May 2022. Previous experience includes roles as Scientist in In vitro Pharmacology at Affibody AB, where immunogenicity assessments and assay development for antidrug antibodies were key responsibilities, and as a Scientist in Bioanalytical Immunology at Sobi, engaging in assay development for preclinical studies. Additional expertise encompasses drug design, pharmaceutical quality, assay development, and biomarker bioanalysis, with extensive academic training culminating in a PhD in Genetics and Immunology from Karolinska Institutet. Dorota began their academic journey with a Master's in Biotechnology from the University of Wroclaw and has contributed to significant research in neuroinflammation, gut microbiota, and immune responses throughout their career.
This person is not in any teams
Xbrane Biopharma AB
Xbrane is a biopharmaceutical company specialized in high demand complex generics.The segment have a high entry barrier, driven by high production complexity and the need of specific Know-How. Xbrane currently possess it own expertise within production of complex generics with slow release formulation and unique technologies for producing Proteinsefficiently.